|
Academic/Biomedical Research
News & Jobs
|
|
|
|
|
|
|
|
|
|
|
|
|
Free Newsletters
Archive
My Subscriptions
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers
Regional News
US & Canada
Biotech Bay
Biotech Beach
Genetown
Pharm Country
BioCapital
BioMidwest
Bio NC
BioForest
Southern Pharm
BioCanada East
US Device
Europe
Asia
Company Profiles
Research Store
Research Events
Post an Event
Real Estate
Business Opportunities
|
|
|
|
|
News | News By Subject | News by Disease |
News By Date | Search News
|
|
|
Tanabe Seiyaku Company Gains MEXT Approval For Its Project On Use Of Human Embryonic Stem Cells
10/19/2005 5:10:04 PM
The cooperative study "Safety Evaluation and Efficacy of Transplantation of Human embryonic stem (ES) Cells in a Monkey Parkinson Disease Model," cosponsored by Tanabe Seiyaku Co., Ltd. (President: Natsuki Hayama) and the Section of Neurology, Department of Internal Medicine, Jichi Medical School (Professor: Imaharu Nakano), part of the project on use of human ES cells was examined by the Human Embryo Research Subcommittee of the Bioethics Committee, Council for Science and Technology, the Minister of Education, Culture, Sports, Science and Technology (MEXT), and the project was confirmed as complying with the Ministry's "Guidelines for Derivation and Use of Human Embryonic Stem Cells."
|
|
|
|
|
|
|
|
|
|
|